Trends in Iran Pharmaceutical Market.

Trends in Iran Pharmaceutical Market. - PDF Download Free
286KB Sizes 1 Downloads 9 Views

Recommend Documents

The structure of the pharmaceutical market in Iran using concentration indices.
The efficiency and function of the pharmaceutical sector, as a vital portion of the health system, have a significant effect on intermediate and final indices of health. In this research, the structure of the pharmaceutical market in Iran was examine

Pharmaceutical Industry in Vietnam: Sluggish Sector in a Growing Market.
Vietnam is a fast growing economy in the Asian region with a significantly high population (over 92 million in 2015). Although still expanding (about 1.1% on average during 2000-2015), the Vietnamese population is considered to be entering the ageing

Drug repurposing in pharmaceutical industry and its impact on market access: market access implications.
Drug repurposing is a group of development strategies employed in order to overcome some of the hurdles innate to drug research and development. Drug repurposing includes drug repositioning, reformulation and combination.

Pharmaceutical market access in emerging markets: concepts, components, and future.
This article intends to consolidate the concepts of pharmaceutical market access and highlight its growing importance in emerging markets. Market access has gained considerable attention worldwide as countries try to contain their escalating healthca

Trends in paediatric clinical pharmacology data in US pharmaceutical labelling.
There is often a lack of safety and efficacy data in the paediatric population at the time of drug approval. Legislative efforts have promoted clinical pharmacology research in this underserved population. We sought to determine the quantity and qual

Trends in pharmaceutical targeting of clinical indications: 1930-2013.
An analysis of FDA-approved new molecular entities (NMEs) reveals trends in therapeutic applications. Four groupings (infectious diseases, cardiovascular diseases, autoimmune/inflammatory diseases and cancer) capture more than 60% of NMEs. Infectious